BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 199262)

  • 41. Cyclic nucleotide phosphodiesterase in rat parotid gland.
    Yokoyama N; Abe M; Furuyama S
    Can J Physiol Pharmacol; 1981 Mar; 59(3):293-9. PubMed ID: 6261905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ca2+-independent cyclic GMP phosphodiesterases from rat liver and HTC hepatoma cells.
    Strewler GJ; Danello MA; Manganiello VC; Vaughan M
    Biochem J; 1983 Aug; 213(2):379-86. PubMed ID: 6311163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
    Strada SJ; Martin MW; Thompson WJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
    [No Abstract]   [Full Text] [Related]  

  • 44. Calmodulin-stimulated cyclic nucleotide phosphodiesterase from Neurospora crassa.
    Ortega Perez R; Van Tuinen D; Marmé D; Turian G
    Biochim Biophys Acta; 1983 Jul; 758(1):84-7. PubMed ID: 6305427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties.
    Minneman KP
    J Neurochem; 1976 Nov; 27(5):1181-9. PubMed ID: 12170605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on cyclic nucleotide metabolism in Tetrahymena pyriformis: partial characterization of cyclic AMP- and cyclic GMP-dependent phosphodiesterases.
    Kudo S; Nakazawa K; Nozawa Y
    J Protozool; 1980 Aug; 27(3):342-5. PubMed ID: 6109021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on the soluble phosphodiesterases of chicken gizzard smooth muscle.
    Birnbaum RJ; Head JF
    Biochem J; 1983 Dec; 215(3):627-36. PubMed ID: 6318728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation, characterization and Ca2+ and calmodulin regulation of cyclic nucleotide phosphodiesterases from human placentae of different ages.
    Tertrin-Clary C; Chenut MC; Acker G; De La Llosa P
    Biochem Int; 1989 Jan; 18(1):99-117. PubMed ID: 2541726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclic nucleotide analogs used to study phosphodiesterase catalytic and allosteric sites.
    Erneux C; Miot F
    Methods Enzymol; 1988; 159():520-30. PubMed ID: 2842616
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver.
    Pyne NJ; Cooper ME; Houslay MD
    Biochem J; 1986 Mar; 234(2):325-34. PubMed ID: 3013156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resolution of soluble rat cardiac phosphodiesterases by high performance liquid chromatography.
    Bode DC; Kanter JR; Brunton LL
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):235-40. PubMed ID: 2856111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ontogenetic changes in levels of phosphodiesterase for adenosine 3':5'-monophosphate and glucosine 3':5'-monophosphate in the lung, brain and heart from guinea pigs.
    Davis CW; Kuo JF
    Biochim Biophys Acta; 1976 Sep; 444(2):554-62. PubMed ID: 183829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of Ca++ on cyclic nucleotide phosphodiesterases of superior cervical ganglion.
    Boudreau RJ; Drummond GI
    J Cyclic Nucleotide Res; 1975; 1(4):219-28. PubMed ID: 177462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
    Sharma RV; Bhalla RC
    Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
    [No Abstract]   [Full Text] [Related]  

  • 55. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein activator of cyclic AMP phosphodiesterase and cyclic nucleotide phosphodiesterase in bovine retina and bovine lens. Activity, subcellular distribution and kinetic parameters.
    Liu YP; Schwartz HS
    Biochim Biophys Acta; 1978 Sep; 526(1):186-93. PubMed ID: 210826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
    Nagasaka A; Hidaka H
    Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of cyclic nucleotide phosphodiesterase activity in human lung fibroblasts.
    Duttagupta C; Rifas L; Makman MH
    Biochim Biophys Acta; 1978 Apr; 523(2):385-94. PubMed ID: 207333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
    Davis CW
    Biochim Biophys Acta; 1982 Jul; 705(1):1-7. PubMed ID: 6288105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 3':5'-cyclic-nucleotide phosphodiesterase in the bovine pituitary gland.
    Nagasaka A; Ohkubo S; Hidaka H
    Biochim Biophys Acta; 1983 Feb; 755(3):481-7. PubMed ID: 6297613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.